| Literature DB >> 30613416 |
Rine Bakkestrøm1, Ann Banke1, Redi Pecini1, Akhmadjon Irmukhamedov1, Søren Kristian Nielsen1, Mads J Andersen1,2, Barry A Borlaug1,3, Jacob Eifer Moller1.
Abstract
Objective: To assess the association between cardiac morphology and function assessed with cardiac MRI (CMRI) and haemodynamics at rest and during exercise in patients with primary mitral regurgitation (MR).Entities:
Keywords: MRI; haemodynamics; mitral regurgitation
Year: 2018 PMID: 30613416 PMCID: PMC6307562 DOI: 10.1136/openhrt-2018-000919
Source DB: PubMed Journal: Open Heart ISSN: 2053-3624
Clinical characteristics
| All patients (n=46) | |
| Age, years | 65±9 |
| Gender, male (%) | 36 (78) |
| Body surface area, m2 | 1.96±0.18 |
| Current smoker (%) | 7 (15) |
| Hypertension (%) | 9 (20) |
| Diabetes mellitus (%) | 0 (0) |
| IHD (%) | 5 (11) |
| Stroke (%) | 1 (4) |
| Intermittent atrial fibrillation (%) | 6 (13%) |
| NYHA class 2 or 3 | 18 (39%) |
| FEV1, L/min | 3.2±0.78 |
| eGFR, mL/min | 80±12 |
| Systolic blood pressure | 134±12 |
| Haemoglobin (mmol/l) | 8.0±0.8 |
| Haematocrit | 0.38±0.03 |
| Medication | |
| ACEi/ARB | 10 (24%) |
| β blocker | 5 (11%) |
| Calcium channel blocker | 6 (13%) |
| Diuretic | 10 (24%) |
| Anticoagulation | 5 (11%) |
| Echocardiographic characteristics | |
| LVEF (%) | 70±7 |
| ERO (cm2) | 0.50±0.25 |
| Regurgitant volume (ml) | 84±46 |
| Bileaflet prolapse (%) | 14 (30%) |
| Posterior prolapse (%) | 41 (89%) |
| Anterior prolapse (%) | 17 (37%) |
| Flail leaflet (%) | 11 (24%) |
| Ruptured chord (%) | 22 (52%) |
Data are number and (%) or mean±SD.
ACEi/ARB, ACE inhibitor / angiotensin 2 receptor blocker; ERO, effective regurgitant orifice; FEV1, forced expiratory volume (1 sec); IHD, ischaemic heart disease; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association functional class; eGFR, estimated glomerular filtration rate.
Cardiac MRI measurements and plasma volume according to regurgitant volume.
| Regurgitant volume <60 mL (N=24) | Regurgitant volume ≥60 mL (N=22) | P value | |
| Plasma volume, mL | 2924±354 | 3050±342 | 0.22 |
| Regurgitant volume, mL | 38±13 | 79±18 | <0.001 |
| Regurgitant fraction, % | 31±10 | 48±8 | <0.001 |
| LV End-Diastolic Volume Index, mL/m2 | 101±14 | 130±22 | <0.001 |
| LV End-Systolic Volume Index, mL/m2 | 39±9 | 48±14 | 0.009 |
| LV ejection fraction, % | 63±8 | 64±6 | 0.71 |
| Total LV Stroke Volume Index, mL/m2 | 63±8 | 83±12 | <0.001 |
| Indexed aorta flow*, mL/m2 | 41±8 | 39±8 | 0.75 |
| LV wall mass index, g/m2 | 57±12 | 70±18 | 0.006 |
| LV mass/LV end-diastolic volume, g/mL | 0.56±0.08 | 0.53±0.12 | 0.42 |
| LA Max Volume Index, mL/m2 | 80±16 | 105±21 | <0.001 |
| LA pre A volume index, mL/m2 | 59±13 | 76±15 | <0.001 |
| LA Minimal Volume Index, mL/m2 | 44±14 | 58±18 | 0.008 |
| LA fractional change, % | 46±9 | 46±8 | 0.76 |
| LA active systolic emptying fraction, % | 27±9 | 26±10 | 0.63 |
| RV End-Diastolic Volume Index, ml/m2 | 68±14 | 70±15 | 0.60 |
| RV End-Systolic Volume Index, ml/m2 | 27±7 | 32±11 | 0.09 |
| RV ejection fraction, % | 60±7 | 55±9 | 0.02 |
| RV Stroke Volume Index, ml/m2, | 41±9 | 38±9 | 0.35 |
Data are mean±SD unless otherwise indicated.
*(Aortic forward flow—aortic backward flow)/body surface area.
LA, left atrial; LV, left ventricular; RV, right ventricular.
Invasive haemodynamic measurements at rest and during exercise according to regurgitated volume on cardiac MRI (CMRI)
| Rest | Peak exercise | |||||
| Regurgitant volume <60 mL | Regurgitant volume vol ≥60 mL | P value | Regurgitant volume <60 mL | Regurgitant volume ≥60 mL | P value | |
| Watts at max. exercise | – | – | – | 111±46 | 129±36 | 0.17 |
| Estimated VO2 (Fick), ml/kg | 2.8±0.8 | 2.6±0.6 | 0.51 | 18.7±6.7 | 18.8±4.3 | 0.67 |
| Heart rate | 66±14 | 67±10 | 0.71 | 122±19 | 130±16 | 0.12 |
| MAP, mm Hg | 89±9 | 91±9 | 0.57 | 106±14 | 112±18 | 0.23 |
| Mean RAP, mm Hg | 6±3 | 7±4 | 0.52 | 11±6 | 10±4 | 0.97 |
| PAP systolic, mm Hg | 27±6 | 32±9 | 0.04 | 57±12 | 63±13 | 0.11 |
| PAP diastolic, mm Hg | 12±3 | 14±5 | 0.11 | 27±6 | 30±6 | 0.09 |
| PAP mean, mm Hg | 18±4 | 21±7 | 0.04 | 41±8 | 45±8 | 0.09 |
| PCWP, mm Hg | 11±3 | 14±4 | 0.002 | 27±7 | 28±7 | 0.44 |
| CO, L/min | 4.9±1.2 | 5.3±1.2 | 0.32 | 13.2±4.0 | 14.2±2.9 | 0.34 |
| CI, l/min/m2 | 2.6±0.5 | 2.6±0.5 | 0.85 | 6.8±1.4 | 7.1±1.3 | 0.41 |
| LV stroke work, g*m | 138±31 | 186±34 | <0.001 | |||
| RV stroke work, g*m | 7.4±3.9 | 7.2±5.8 | 0.89 | |||
| PAPI | 3.0±1.4 | 3.4±2.2 | 0.39 | 3.1±1.4 | 3.1±1.1 | 0.94 |
| SVO2 | 72±6 | 75±5 | 0.11 | 35±11 | 36±11 | 0.77 |
| Lactate, mmol/L | 0.6±0.3 | 0.6±0.2 | 0.79 | 4.1±1.7 | 5.3±1.8 | 0.04 |
Data are mean±SD.
CI, Cardiac Index; CO, cardiac output; LV, left ventricular; MAP, mean arterial pressure; PAP, pulmonary artery pressure; PAPI, Pulmonary Pulsatility Index; PCWP, pulmonary capillary wedge pressure; RAP, right atrial pressure; RV, right ventricular; SVO2, mixed venous oxygen saturation; VO2, maximal oxygen consumption.
Figure 1Scatterplot demonstrating a good association between regurgitant volume assessed on cardiac MRI and pulmonary capillary wedge pressure (PCWP) at rest (A) but not with exercise (B).
Figure 2Scatterplot demonstrating a good association between left atrial (LA) maximal volume index assessed on cardiac MRI and pulmonary capillary wedge pressure (PCWP) at rest (A) but no association with exercise (B).
Figure 3Single beat estimation of end-diastolic pressure volume relationship (EDPVR) in patients divided according to a normal pulmonary capillary wedge pressure (PCWP) ≤12 mm Hg at rest (A) and a PCWP ≤28 mm Hg with peak exercise (B). Patients with abnormal PCWP at rest had a right shift of EDPVR suggestive of a more compliant left ventricle (LV). This was the opposite in patients with increased PCWP with exercise where a left shift of EDPVR was seen suggestive of less compliance.